Biotechnology News

October 8, 2014

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--BioFlorida, Florida’s life sciences association, will host the state’s life science industry during its 17th Annual Life Sciences Conference, October 12–14, 2014 at the Harbor Beach Marriott in Ft....

October 8, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present data from its Phase 2a study of ARC-520 against chronic hepatitis B infection and preclinical data on ARC-AAT at the AASLD Liver Meeting.

October 8, 2014

CHANDLER, Ariz.--(BUSINESS WIRE)--Arizona BioIndustry Association (AZBio) will honor 11 Arizona Legislators for service to the community and for championing research, education, innovation, the growth of Arizona's Bioscience Sector.

October 8, 2014

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix elects its President and CEO, Paul D. Hartung, as Chairman of the Board, and welcomes new director, Dr. Christine de los Reyes, Alopexx Enterprises

October 8, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) has been recognized for its sustainability leadership by several external organizations, including the Healthcare Businesswomen’s Association’s 2014 ACE Award for commitment...

October 8, 2014

BOULDER, Colo. & BEVERLY, Mass.--(BUSINESS WIRE)--Enzymatics launched a new data analysis platform for next-generation sequencing applications. The Archer Analysis Pipeline detects and characterizes cancer-causing gene fusions and mutations...

October 8, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies against serious infectious diseases, announced today the presentation of final data...

October 8, 2014

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Senior Scientific LLC, a subsidiary of Manhattan Scientifics, Inc. (OTCQB: MHTX), is currently collaborating with The University of Texas MD Anderson Cancer Center (MDACC) to advance, demonstrate and validate a...

October 8, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist to Present New Data from Study of fidaxomicin in Children with Clostridium Difficile-Associated Diarrhea at IDWeek 2014

October 8, 2014

BOSTON--(BUSINESS WIRE)--MetaStat, Inc. a molecular diagnostic company focused on understanding and treating systemic metastasis, has its licensed technology spotlighted in a WABC-TV news special that aired on 10/4/14.

October 8, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today announced that it will give one oral presentation and two poster presentations on data from its ongoing Phase II...

October 8, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported that total revenues for the third quarter of 2014 are expected to be approximately $15 million and that non-GAAP earnings per diluted share are expected...

October 8, 2014

NEW YORK--(BUSINESS WIRE)--This October, Pfizer Inc. is uniting with leaders in the breast cancer community in a public call-to-action to expand the breast cancer dialogue to include metastatic breast cancer. This comes after a first-of-its-kind...

October 8, 2014

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Sparton Corporation (NYSE:SPA) today announced that it will make the audio portion of its upcoming Investor Day presentation available via webcast. Listeners may access the live audio portion of the presentation...

October 8, 2014

ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) today announced fiscal year 2014 results slightly above the high end of its guidance range on the strength of its global seeds and traits business, the biggest driver of growth for the year...

October 8, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, a privately held, clinical-stage company developing recombinant vaccines that are administered by tablet rather than by injection, today announced that Vaxart founder and chief scientific...

October 8, 2014

LEWISVILLE, Texas & CLEVELAND--(BUSINESS WIRE)--med fusion, an integrated molecular center of excellence and clinical trials service organization and GenomOncology, an Ohio based genomics technology and services provider, today announced a...

October 8, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today it will present the results of a Phase 2, randomized study to evaluate co-administration of the company’s investigational meningococcal group B vaccine, bivalent recombinant LP2086...

October 8, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Aphios today announced that it has been granted United States Patent for the nanotechnology formulation of poorly soluble compounds for difficult to formulate and deliver drugs.

October 8, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. to Raise $13.5 Million in Registered Direct Offering

October 8, 2014

DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (“Neos”), a specialty pharmaceutical company with a portfolio of novel and proprietary oral drug delivery technologies as well as a late-stage pipeline of innovative...

October 8, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) announced today that researchers will present a poster at IDWeek 2014 showing the preclinical activity of eravacycline, a novel tetracycline in late-stage clinical...

October 8, 2014

NEEDHAM, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it will present new data at the 12th International...

October 8, 2014

WASHINGTON--(BUSINESS WIRE)--As a cap to Clinical Research Innovation Month, the ACRO today released a report titled Clinical Research: A Legacy of Innovation, A Future of Transformed Medicine

October 8, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that it has closed...

October 8, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--PROVECTUS’ INTRALESIONAL PV-10 CLINICAL DATA TO BE PRESENTED TO THE EURASIAN FEDERATION OF ONCOLOGY; III Eurasian Melanoma and Skin Cancers Forum, October 10-12, 2014

October 8, 2014

SEATTLE--(BUSINESS WIRE)--Blaze Bioscience announces NCI SBIR Phase II funding for clinical trial of Tumor Paint(TM) BLZ-100 in sarcoma. BLZ-100 clinical program expands beyond brain and skin cancers.

October 8, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Essen BioScience, Inc., a leading provider of critical analytical instrumentation, software, reagents and services used in cell-based life science research, names Brett Williams President and CEO.

October 8, 2014

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEngine Inc. (TWO: 4162), a biopharmaceutical company developing new cancer treatments, and Nanobiotix S.A. (Euronext: NANO), a clinical-stage nanomedicine company pioneering in novel approaches for local...

October 8, 2014

DUNDEE, Scotland--(BUSINESS WIRE)--Ubiquigent and University of Dundee Announce Collaboration to Design, Develop and Market Novel Ubiquitin System Targeted Compound Libraries.

October 8, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Diagenic ASA – Signed final agreement to acquire NEL Hydrogen AS – extended announcement Reference is made to the stock exchange announcement made by Diagenic ASA ("Diagenic" or the "Company") on 8...

October 8, 2014

CROISSY-BEAUBOURG, France & MONTPELLIER, France--(BUSINESS WIRE)--THERADIAG - Monitoring of biotherapeutic treatments of Crohn’s disease could produce savings of more than €130 million in France

October 7, 2014

WASHINGTON--(BUSINESS WIRE)--The USDA today issued a report and commissioned a larger report on the jobs and economic opportunities created by the biobased products and renewable chemical industries, which BIO represents.

October 7, 2014

RIVERSIDE, Calif.--(BUSINESS WIRE)--ieCrowd, the discovery-to-market commercialization platform for innovations with the potential to solve global challenges, today announced plans to commercialize a new class of intelligent supplemental oxygen...

October 7, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that Max Link, Ph.D., Chairman of the Board of Directors of Alexion, passed away unexpectedly on October 5 while traveling on business.

October 7, 2014

WITTEN, Germany--(BUSINESS WIRE)--According to preliminary, unaudited figures Sangui BioTech International, Inc. yielded revenues from royalties and product sales of more than USD70,000 in the course of the first quarter of its financial year...

October 7, 2014

NEW YORK--(BUSINESS WIRE)--M&A firm advises leading market access agency in the pharmaceutical and biotech industries in its sale to the health behavior experts of Ogilvy & Mather.

October 7, 2014

MILFORD, Conn.--(BUSINESS WIRE)--Kubtec announces FDA approval of the world’s first specimen tomosynthesis radiography system, providing high resolution 3D image slices for comprehensive margin confirmation of excised breast tissue.

October 7, 2014

SINGAPORE--(BUSINESS WIRE)--PrIME Biologics Private Limited today announced investments from Xeraya Capital Labuan Ltd via its affiliate, Pulau Manukan Ventures Labuan Ltd, and JP Asia Prime Capital Pte Ltd. This investment will enable PrIME...

October 7, 2014

CRANFORD, N.J.--(BUSINESS WIRE)--Paragon Solutions, Inc., an advisory consulting and systems integration firm, today announced several appointments to its Life Sciences Research and Development (R&D) practice team to better serve its growing...

October 7, 2014

ANAHEIM, Calif.--(BUSINESS WIRE)--The Health Care IT Value Model is unveiled to a crowd of 1,000+ health and human services providers, setting the groundwork for improving health care.

October 7, 2014

WAPATO, Wash.--(BUSINESS WIRE)--Pace International LLC announced it has received an Experimental Use Permit (EUP) from the U.S. EPA for FYSIUM™, a new 1-MCP technology that will help apple packers in the United States improve the quality and...

October 7, 2014

NEWTOWN, Pa.--(BUSINESS WIRE)--Helius Medical Technologies is granted U.S. Patent No. 8,849,407, “Non-Invasive Neuromodulation (NINM) for Rehabilitation of Brain Function

October 7, 2014

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences and ArborGen agree to incorporate Arcadia’s water use efficiency (WUE) and nitrogen use efficiency (NUE) technologies.

October 7, 2014

MONROVIA, Calif.--(BUSINESS WIRE)--Immunotech Laboratories, Inc. (OTCMARKETS: IMMB) and Immunotech Laboratories, BG. recently announced the successful completion of Phase I and Phase II field trials in Bulgaria of the Company’s HIV/AIDS and...

October 7, 2014

NEW YORK--(BUSINESS WIRE)--Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing DNA-based therapeutics for rare genetic diseases, announced today the addition of Professor Paola Leone, PhD, Director of the Cell and...